🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/06/2016 | 106,00 | 107,49 | 101,47 | 102,11 | -3,92% | 5,68% | 963.200 |
| 16/06/2016 | 104,20 | 106,52 | 103,10 | 106,28 | +1,69% | 3,28% | 537.000 |
| 15/06/2016 | 105,00 | 106,08 | 101,52 | 104,51 | -2,56% | 4,34% | 987.600 |
| 14/06/2016 | 109,63 | 110,37 | 106,27 | 107,26 | -2,54% | 3,74% | 699.700 |
| 13/06/2016 | 111,06 | 112,75 | 109,40 | 110,06 | -1,16% | 3,02% | 564.500 |
| 10/06/2016 | 111,63 | 112,71 | 109,51 | 111,35 | -1,57% | 2,87% | 334.700 |
| 09/06/2016 | 116,76 | 117,83 | 113,13 | 113,13 | -3,34% | 4,03% | 534.200 |
| 08/06/2016 | 116,62 | 117,51 | 114,22 | 117,04 | +0,60% | 2,82% | 287.200 |
| 07/06/2016 | 118,46 | 118,99 | 116,09 | 116,34 | -2,49% | 2,45% | 382.500 |
| 06/06/2016 | 116,77 | 119,77 | 114,55 | 119,31 | +2,58% | 4,47% | 409.700 |
| 03/06/2016 | 120,53 | 120,53 | 115,75 | 116,31 | -3,90% | 3,97% | 499.200 |
| 02/06/2016 | 118,79 | 121,69 | 118,58 | 121,03 | +1,60% | 2,62% | 573.000 |
| 01/06/2016 | 118,34 | 119,59 | 118,08 | 119,12 | +0,04% | 1,28% | 579.700 |
| 31/05/2016 | 118,37 | 119,31 | 117,54 | 119,07 | +1,10% | 1,50% | 855.700 |
| 27/05/2016 | 116,98 | 117,89 | 115,64 | 117,78 | +0,54% | 1,92% | 406.100 |
| 26/05/2016 | 117,50 | 118,90 | 116,87 | 117,15 | -0,53% | 1,73% | 441.700 |
| 25/05/2016 | 117,83 | 119,98 | 116,85 | 117,77 | +0,99% | 2,66% | 558.200 |
| 24/05/2016 | 114,00 | 117,81 | 113,99 | 116,62 | +2,14% | 3,35% | 642.700 |
| 23/05/2016 | 113,78 | 115,96 | 113,47 | 114,18 | +0,49% | 2,19% | 649.500 |
| 20/05/2016 | 111,02 | 114,12 | 110,79 | 113,62 | +2,55% | 3,00% | 442.000 |
| 19/05/2016 | 111,97 | 114,26 | 109,69 | 110,80 | -1,47% | 4,08% | 449.000 |
| 18/05/2016 | 110,21 | 114,03 | 109,83 | 112,45 | +1,45% | 3,81% | 548.000 |
| 17/05/2016 | 109,95 | 112,49 | 108,75 | 110,84 | +0,20% | 3,40% | 524.000 |
| 16/05/2016 | 111,23 | 111,35 | 107,68 | 110,62 | -0,77% | 3,30% | 640.800 |
| 13/05/2016 | 109,47 | 113,33 | 108,42 | 111,48 | +2,06% | 4,49% | 600.100 |
| 12/05/2016 | 108,98 | 110,42 | 108,09 | 109,23 | +0,73% | 2,14% | 850.900 |
| 11/05/2016 | 112,27 | 112,27 | 108,04 | 108,44 | -3,06% | 3,77% | 505.400 |
| 10/05/2016 | 112,19 | 112,99 | 110,01 | 111,86 | +0,22% | 2,66% | 826.700 |
| 09/05/2016 | 108,58 | 112,48 | 108,25 | 111,61 | +3,19% | 3,90% | 692.700 |
| 06/05/2016 | 107,65 | 109,44 | 105,52 | 108,16 | +0,36% | 3,64% | 629.000 |